Skip to main content
. 2019 May;8(2):80–88. doi: 10.5582/irdr.2019.01068

Table 2. The rare disease drugs which are reimbursed by local government.

Province/City The Rare Diseases Involved Main Policy
Qingdao (39) Multiple sclerosis: Recombinant human interferon for injection (β-1b);
Hyperphenylalanemia: Sapropterin Dihydrochloride Tablets;
Idiopathic Pulmonary Artery Hypertension: Bosentan Tablets;
Gaucher disease: Imiglucerase for Injection;
▪) Supplementary Medical Insurance Funds reimbursed 80%.
▪) Large amount of security section, personal burden of more than 50,000 yuan/year, reimbursed 70%, annual maximum payment was 200,000 yuan.
▪) Insured people in low-and middle-income families can also enjoy the special medical subsidy provided by the civil administration.
Shanghai (40) Haemophilia: Recombinant Human Coagulation Factor Ⅸ for Injection.
Children's Hospitalization Fund: Pompeii Disease, Fabre Disease, Gaucher Disease, Mucopolysaccharidosis;
Special Rescue Funds for Lysosomal Storage: Diseases Associated with Lysosomal Storage.
▪) Children's Hospitalization Funds reimbursed RMB10,000 (children only).
▪) Special Rescue Funds for Lysosomal Storage provide relief for the remaining co-payments of patients.
Zhejiang (41) Gaucher Disease: Imiglucerase for Injection;
Hyperphenylalanemia: Sapropterin Dihydrochloride Tablets;
Idiopathic Pulmonary Fibrosis: Nintedanib;
Idiopathic Pulmonary Artery Hypertension: Ambrisentan tablets;
Amyotrophic Lateral Sclerosis: Riluzole.
▪) Medical expenses other than medicare reimbursement were resolved by financial arrangement funds through special assistance.
▪) Special funds were subsidized by provincial finance through civil assistance
Henan (42) Haemophilia, Phenylketonuria etc. ▪) Included in the list of severe diseases
Shenzhen (43) Idiopathic Pulmonary Arterial Hypertension: Bosentan Tablets;
Crohn's Disease: Infliximab for Injection.
▪) Included in the supplementary medical insurance list, reimburse 70%
Chengdu (44) Idiopathic Pulmonary Arterial Hypertension: Bosentan Tablets;
Crohn's Disease: Infliximab for Injection
▪) Included in the medical insurance drug list for severe diseases, reimburse 70% and the limitation is 150,000 yuan at most.